Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-02
1997-03-04
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31335
Patent
active
056079648
ABSTRACT:
Treating patients prophylactically and therapeutically with dicitrate cyclic diester (dicitrate) can prevent or reduce the effects of calcification-related disease, including some types of kidney stones.
REFERENCES:
patent: 4399003 (1983-08-01), Sarig et al.
patent: 4888182 (1989-12-01), Pak
patent: 5137722 (1992-08-01), Costello
Boyce, W. H. (1979) "Epidemiology of Lithiasis in the United States" XVIIIth C.M. Congress of the International Society of Urology, Paris, Kongressbericht, Tome 1, pp. 79-86.
Sierakowski, R. et al. (1978) "The Frequency of Urolithiasis in Hospital Discharge Diagnoses in the United States" Investigative Urology 15(6):438-441.
Thomas, W. C. Jr. (1976) "Renal Calculi: A Guide to Management", Charles C. Thomas, Publisher, Springfield, IL, 177 pages.
Davis, Geroge K. et al. (1974) "Urolithiasis", Geochemistry and the Environment, National Academy of Science, Washington, pp. 133-138.
Zhmurov, V. A. et al. (1991) "Parameters of Destabilized Cellular Membrane and Urolithiasis" Urol. Nefrol-Moscow May-Jun. (3):12-15.
Azoury, R. et al. (1990) "Hydration Feature of Urinary Compounds" Urological Research 18:7-11.
Schrier, E. E. et al. (1979) "Macromolecular Inhibitors of Calcium Oxalate Crystal Growth and Aggregation in Urine" Oxalate in Human Biochemistry and Clinical Pathology, pp. 22-27.
Bose, P. K., S. N. Bhatacharyya (1936) "On the Constitution of an Acid Isolated from Pineapple" Science and Culture 2:162.
Thomas, William Thomas, Jr. MD (1988) "Kidney Stones, Urine, and Cement" American Journal Kidney Disease 37(11):861-862.
Coe, F. L. et al. (1991) "Inhibitors Within the Nephron" American Journal of Kidney Diseases 17(4):407-413.
Lewis, B. D. (1990) "Determination of Citrate in Urine by Simple Direct Photometry-Letters to the Editor" Clinical Chemistry 35(3):578.
Varaprasad, D. V. P. R. et al. (1986) "Synthesis of polyfunctional hydroxmic acids for potential use in iron chelation therapy" Chemical Abstracts 105(1):43, abstract No. 458.
Millan, A. et al. (1987) "Determination of Citrate in Urine by Simple Direct Photometry" Clinical Chemistry 33(7):1259-1260.
Batich Christopher D.
Purich Daniel L.
Thomas, Jr. William C.
Spivack Phyllis G.
University of Florida
LandOfFree
Clinical marker and therapeutic agent in kidney stone disease an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Clinical marker and therapeutic agent in kidney stone disease an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Clinical marker and therapeutic agent in kidney stone disease an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2146275